Simon Yates fails drugs test after ‘using asthma inhaler’ to plunge British Cycling deeper into crisis – Telegraph.co.uk


Telegraph.co.uk

Simon Yates fails drugs test after 'using asthma inhaler' to plunge British Cycling deeper into crisis
Telegraph.co.uk
A disastrous week got worse for British Cycling last night after it emerged that Simon Yates, the former points race world champion and a contender for a spot on the GB road team at Rio de Janeiro this summer, failed an in-competition drugs test
Yates fails drugs test using asthma inhaler: teamReuters
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC Sport
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Daily Mail –The Guardian
all 41 news articles »

View full post on asthma – Google News

KaloBios Pharma pulls plug on asthma drug, shares plunge – Reuters

KaloBios Pharma pulls plug on asthma drug, shares plunge
Reuters
(Reuters) – Shares of KaloBios Pharmaceuticals Inc fell nearly 50 percent in extended trade after the company said it would stop developing an asthma drug that failed in a mid-stage study. The drug, KB003, failed to bring about a clinically meaningful 
KaloBios stock slides; to stop asthma studyMarketWatch
KaloBios: KB003 Fails To Meet Primary Goal In Phase 2 Asthma StudyRTT News

all 19 news articles »

View full post on asthma – Google News